These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2184824)

  • 21. Uses and abuses of enzyme therapy in cystic fibrosis.
    Durie P; Kalnins D; Ellis L
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):2-13. PubMed ID: 9709382
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of liquid pancreatic enzymes on the assimilation of fat in different liquid formula diets.
    Hauenschild A; Ewald N; Klauke T; Liebchen A; Bretzel RG; Kloer HU; Hardt PD
    JPEN J Parenter Enteral Nutr; 2008; 32(1):98-100. PubMed ID: 18165455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of maldigestion associated with pancreatic insufficiency.
    Perry RS; Gallagher J
    Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of Creon and Eurobiol in the treatment of exocrine pancreatic insufficiency in adults].
    Emerit J; Levy VG; Paris JC; Quinton A; Sarles H
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):263-7. PubMed ID: 3207353
    [No Abstract]   [Full Text] [Related]  

  • 25. [Digestive and nutritional management of adults with cystic fibrosis].
    Marteau P; Munck A; Moreau J; Navarro J
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):785-97. PubMed ID: 11076388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of treatment for pancreatic exocrine insufficiency in dogs with ligated pancreatic ducts.
    Pidgeon G; Strombeck DR
    Am J Vet Res; 1982 Mar; 43(3):461-4. PubMed ID: 6918196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal chymotrypsin and elastase-1 determination on one single stool collected at random: diagnostic value for exocrine pancreatic status.
    Molinari I; Souare K; Lamireau T; Fayon M; Lemieux C; Cassaigne A; Montaudon D
    Clin Biochem; 2004 Sep; 37(9):758-63. PubMed ID: 15329313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of Panzytrat in the replacement therapy of exocrine pancreatic insufficiency (an analytical review)].
    Karamysheva EI; Lobanova EG
    Eksp Klin Gastroenterol; 2002; (4):47-50, 132. PubMed ID: 12503276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy.
    Braden B; Picard H; Caspary WF; Posselt HG; Lembcke B
    Z Gastroenterol; 1997 Feb; 35(2):123-9. PubMed ID: 9066102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of pancreatic insufficiency].
    Ansaldi N; Santini B; Garbagni C
    Pediatr Med Chir; 1983; 5(4):149-55. PubMed ID: 6557569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
    Farkas G; Leindler L; Mihalovits G
    Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis.
    Dickinson CJ; Reed MD; Stern RC; Aronoff SC; Yamashita TS; Blumer JL
    Pediatr Res; 1988 Apr; 23(4):388-92. PubMed ID: 3374992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications and successes of surgical and conservative therapy: chronic pancreatitis].
    Fölsch UR
    Z Gastroenterol Verh; 1989 Jul; 24():104-6. PubMed ID: 2474916
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.
    Stapleton FB; Kennedy J; Nousia-Arvanitakis S; Linshaw MA
    N Engl J Med; 1976 Jul; 295(5):246-8. PubMed ID: 934188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measurement of fecal elastase 1 by immunoreactivity: a new indirect test of the pancreatic function].
    Stein J; Schoonbroodt D; Jung M; Lembcke B; Caspary WF
    Gastroenterol Clin Biol; 1996; 20(5):424-9. PubMed ID: 8761139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation.
    Lancellotti L; D'Orazio C; Mastella G; Mazzi G; Lippi U
    Eur J Pediatr; 1996 Apr; 155(4):281-5. PubMed ID: 8777920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.